|
|

|
| New Antibodies : |
|
|
|
| |
Name |
Cat # |
Applications |
Species Reactivity |
| |
|
2152-1 |
WB, IHC, ICC, IP |
Hu + |
| |
|
2202-1 |
WB, FC, IP |
Hu + |
| |
|
2132-1 |
WB, ICC |
Hu + |
| |
|
2153-1 |
WB |
Hu +, Ms+, Rt+ |
| |
|
2186-1 |
WB, IHC, ICC, FC |
Hu + |
| |
|
2199-1 |
WB |
Hu +, Ms+, Rt+ |
| |
|
2219-1 |
WB, IP |
Hu +, Ms+, Rt+ |
| |
|
2156-1 |
WB, IP |
Hu +, Ms+, Rt+ |
| |
|
2204-1 |
WB, IHC, ICC |
Hu + |
| |
|
2190-1 |
WB, IHC, ICC, IP |
Hu +, Ms+, Rt+ |
| |
|
2187-1 |
WB, IHC, IP |
Hu +, Ms+, Rt+ |
| |
|
2154-1 |
WB, ICC, IP |
Hu +, Ms+, Rt+ |
| |
|
2155-1 |
WB, IP |
Hu +, Ms+, Rt+ |
| |
|
2158-1 |
WB, FC |
Hu +, Ms+, Rt+ |
| |
|
2157-1 |
WB, IHC, ICC, IP, FC |
Hu +, Ms+, Rt+ |
| |
|
2151-1 |
WB, IHC, ICC |
Hu + |
| |
|
2188-1 |
WB |
Hu + |
| |
|
2197-1 |
WB |
Hu + |
| |
|
2200-1 |
WB, IHC, ICC |
Hu +, Ms+, Rt+ |
| |
| New Kits: |
| |
|
6000-1 |
Antibody Purification |
See Product Insert |
| |
|
APS-D100 |
Antibody Purification |
See Product Insert |
Don't see what you are looking for?
Send us your suggestion for an antibody that you would like to see developed.
|

EpiMAX Affinity Protein Purification Kit and System offers one stop solution for your purification needs.
EpiMAX™ Affinity Purification kit is based on Epitomics ASA (Activated Serial-A) Matrix Gel Technology which provides several benefits compared to traditional peptide based purification system:
-
Higher antibody binding capacity and yield
- Less protocol steps, which equal less purification time
- Antibody purity of 95% or greater.
>Learn more the benefits of EpiMAX Affinity Purification Kit.
>For large scale purification, check out EpiMAX Affinity Purification System.
Images: EpiMAX vs. Leading Vendor's Kit comparsion result -
Click images for more info.
|
|
 |
 |
CUstom Rabbit Monoclonal Antibody Service

• More diverse epitope recognition
• Improved immune response to small-size epitopes
• High specificity and affinity
• Greatly improved response to mouse antigens
Request More Information |
Copyright © 2008 Epitomics, Inc. |
|